Skip to main content

RGC

Stock
Health Care
Drug Manufacturers - Specialty & Generic

Performance overview

RGC Price
Price Chart

Forward-looking statistics

Beta
0.24
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Company info

SectorHealth Care
IndustryDrug Manufacturers - Specialty & Generic
Employees12
Market cap$61.2M

Fundamentals

Enterprise value$8.6B
Revenue$0.0
Revenue per employee—
Profit margin0.00%
Debt to equity1.04

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.01
Dividend per share—
Revenue per share—
Avg trading volume (30 day)$26M
Avg trading volume (10 day)$41M
Put-call ratio—

Macro factor sensitivity

Growth+2.2
Credit-1.5
Liquidity+2.0
Inflation+1.7
Commodities-0.9
Interest Rates+1.1

Valuation

Dividend yield0.00%
PEG Ratio—
Price to sales—
P/E Ratio—
Enterprise Value to Revenue—
Price to book1642.14

Upcoming events

Next earnings dayFebruary 9, 2017
Next dividend day—
Ex. dividend day—

News

This Chinese Herb Stock Is Now Bigger Than Super Micro And Reddit

Regencell Bioscience Holdings Ltd. RGC, a Hong Kong-based biotech startup with no reported revenue, has gained more than 59,000% in 2025.

Benzinga (June 17, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free